1 In an air pouch-type allergic inflammation model in rats, leucocytes that had infiltrated into the pouch fluid collected 4 h after the antigen challenge produced proteinaceous chemotactic factors for neutrophils when they were incubated in the medium. 2 To clarify the mechanism of activation of the infiltrated leucocytes in producing these factors, the effects of protein kinase inhibitors on neutrophil chemotactic factor production were examined. 3 When the infiltrated leucocytes were incubated for 4 h in medium containing the non-selective protein kinase inhibitor K-252a (1-100 ng ml-', 2.14-214 nM), the tyrosine kinase inhibitor genistein (1-50 1tgml', 3.7-185 p M), and the more selective protein kinase C inhibitor H-7 (5-100 A gml', 13.7-274 gM); neutrophil chemotactic activity in the conditioned medium was decreased in a concentration-dependent manner, but the adenosine 3':5'-cyclic monophosphate (cAMP)-dependent protein kinase inhibitor H-89 (1-10Ongml1', 2.24-2240nM) showed no effect.4 Isoelectric focusing of the conditioned medium revealed that the leucocytes produced two neutrophil chemotactic factors, leucocyte-derived neutrophil chemotactic factor (LDNCF) 1 and LDNCF-2. Treatment of the leucocytes with K-252a, genistein, and H-7, but not H-89, inhibited production of both LDNCF-1 and LDNCF-2. 5 These results suggest that activation of tyrosine kinase and protein kinase C, but not cAMPdependent protein kinase, is responsible for the production of LDNCF-1 and LDNCF-2. 6 The steroidal anti-inflammatory drug dexamethasone and the protein synthesis inhibitor cycloheximide inhibited neutrophil chemotactic factor production in a concentration-dependent manner. Timecourse experiments showed that the inhibitory effect by dexamethasone was apparent even 30 min after the incubation. 7 Mechanism for inhibiting the production of LDNCF-1 and LDNCF-2 by dexamethasone is also discussed.